Skip to main content

Davenport & Co LLC

SEC CIK
0000887777
Latest filing
Jul 13, 2026

BSX holding history

Boston Scientific Corp in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BSX overviewAll 13F holders of BSXFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
21
Since Q1 2021
Holdings of BSX by Davenport & Co LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−10,749−100.0%Sold outHolders
Q1 202610,749$674.5K<0.1%−3,863−26.4%ReducedHolders
Q4 202514,612$1.39M<0.1%−328−2.2%ReducedHolders
Q3 202514,940$1.46M<0.1%+1,332+9.8%AddedHolders
Q2 202513,608$1.46M<0.1%−49−0.4%ReducedHolders
Q1 202513,657$1.38M<0.1%+1,828+15.5%AddedHolders
Q4 202411,829$1.06M<0.1%+561+5.0%AddedHolders
Q3 202411,268$944.3K<0.1%−6−0.1%ReducedHolders
Q2 202411,274$868.2K<0.1%+2,467+28.0%AddedHolders
Q1 20248,807$603.2K<0.1%+34+0.4%AddedHolders
Q4 20238,773$507.2K<0.1%+22+0.3%AddedHolders
Q3 20238,751$462.1K<0.1%00.0%UnchangedHolders
Q2 20238,751$473.3K<0.1%−671−7.1%ReducedHolders
Q1 20239,422$471.4K<0.1%−728−7.2%ReducedHolders
Q4 202210,150$470.0K<0.1%−15,076−59.8%ReducedHolders
Q3 202225,226$977.0K<0.1%+14,641+138.3%AddedHolders
Q2 202210,585$395.0K<0.1%−288−2.6%ReducedHolders
Q1 202210,873$482.0K<0.1%−728−6.3%ReducedHolders
Q4 202111,601$493.0K<0.1%−933−7.4%ReducedHolders
Q3 202112,534$544.0K<0.1%−2,178−14.8%ReducedHolders
Q2 202114,712$629.0K<0.1%+3,708+33.7%AddedHolders
Q1 202111,004$425.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.